The development of ATMP is a long and rigorous process that requires transversal knowledge and daily support. The heterogeneity of cell therapy products necessarily requires agility from your CDMO partner.
This is why our highly skilled teams are focused and mobilized to provide phased and adapted solutions to the clients’ needs.